Abstract
Histaminergic signalling constitutes an attractive target for treatment of neuropsychiatric disorders. One obstacle to developing new pharmacological options has been failure to identify putative specific histamine transporter responsible for histamine clearance. Although high-affinity histamine uptake was detected in neonatal cortical astrocytes, its existence in other brain regions remains largely unexplored. We investigated whether cerebellar and striatal astrocytes participate in histamine clearance and evaluated the role of organic cation transporters (OCT) in astroglial histamine transport. Kinetic and pharmacological characteristics of histamine transport were determined in cultured astrocytes derived from neonatal rat cerebellum, striatum and cerebral cortex. As well as astrocytes of cortical origin, cultured striatal and cerebellar astrocytes displayed temperature-sensitive, high-affinity histamine uptake. Exposure to ouabain or Na+-free medium, supplemented with choline chloride markedly depressed histamine transport in cortical astrocytes. Conversely, histamine uptake in striatal and cortical astrocytes was ouabain-resistant and was only partially diminished during incubation in the absence of Na+. Also, histamine uptake remained unaltered upon exposure to OCT inhibitor corticosterone, although OCTs were expressed in cultured astrocytes. Finally, histamine transport in cerebellar and striatal astrocytes was not sensitive to antidepressants. Despite common characteristics, cerebellar astrocytes had lower affinity, but markedly higher transport capacity for histamine compared to striatal astrocytes. Collectively, we provide evidence to suggest that cerebellar, striatal as well as cortical astrocytes possess saturable histamine uptake systems, which are not operated by OCTs. In addition, our data indicate that Na+-independent histamine carrier predominates in cerebellar and striatal astrocytes, whereas Na+-dependent transporter underlies histamine uptake in cortical astrocytes. Our findings implicate a role for histamine transporters in regulation of extracellular histamine concentration in cerebellum and striatum. Inhibition of histamine uptake might represent a viable option to modulate histaminergic neurotransmission.
Similar content being viewed by others
References
Haas HL, Sergeeva OA, Selbach O (2008) Histamine in the nervous system. Physiol Rev 88(3):1183–1241. doi:10.1152/physrev.00043.2007
Passani MB, Blandina P (2011) Histamine receptors in the CNS as targets for therapeutic intervention. Trends Pharmacol Sci 32(4):242–249. doi:10.1016/j.tips.2011.01.003
Iversen L (2006) Neurotransmitter transporters and their impact on the development of psychopharmacology. Br J Pharmacol 147(Suppl 1):S82–S88. doi:10.1038/sj.bjp.0706428
Schwartz JC, Arrang JM, Garbarg M, Pollard H, Ruat M (1991) Histaminergic transmission in the mammalian brain. Physiol Rev 71(1):1–51
Haas H, Panula P (2003) The role of histamine and the tuberomamillary nucleus in the nervous system. Nat Rev Neurosci 4(2):121–130. doi:10.1038/nrn1034
Merickel A, Edwards RH (1995) Transport of histamine by vesicular monoamine transporter-2. Neuropharmacology 34(11):1543–1547
Sakurai E, Oreland L, Nishiyama S, Kato M, Watanabe T, Yanai K (2006) Evidence for the presence of histamine uptake into the synaptosomes of rat brain. Pharmacology 78(2):72–80. doi:10.1159/000095637
Barnes WG, Hough LB (2002) Membrane-bound histamine N-methyltransferase in mouse brain: possible role in the synaptic inactivation of neuronal histamine. J Neurochem 82(5):1262–1271
Rafalowska U, Waskiewicz J, Albrecht J (1987) Is neurotransmitter histamine predominantly inactivated in astrocytes? Neurosci Lett 80(1):106–110
Huszti Z, Imrik P, Madarasz E (1994) [3H]histamine uptake and release by astrocytes from rat brain: effects of sodium deprivation, high potassium, and potassium channel blockers. Neurochem Res 19(10):1249–1256
Huszti Z, Rimanoczy A, Juhasz A, Magyar K (1990) Uptake, metabolism, and release of [3H]-histamine by glial cells in primary cultures of chicken cerebral hemispheres. Glia 3(3):159–168. doi:10.1002/glia.440030303
Osredkar D, Burnik-Papler T, Pecavar B, Kralj-Iglic V, Krzan M (2009) Kinetic and pharmacological properties of [(3)H]-histamine transport into cultured type 1 astrocytes from neonatal rats. Inflamm Res 58(2):94–102. doi:10.1007/s00011-009-8103-4
Perdan-Pirkmajer K, Pirkmajer S, Cerne K, Krzan M (2012) Molecular and kinetic characterization of histamine transport into adult rat cultured astrocytes. Neurochem Int 61(3):415–422. doi:10.1016/j.neuint.2012.05.002
Perdan-Pirkmajer K, Mavri J, Krzan M (2010) Histamine (re)uptake by astrocytes: an experimental and computational study. J Mol Model 16(6):1151–1158. doi:10.1007/s00894-009-0624-9
Huszti Z, Magyar K, Kalman M (1990) Contribution of glial cells to histamine inactivation. Agents Actions 30(1–2):237–239
Huszti Z, Prast H, Tran MH, Fischer H, Philippu A (1998) Glial cells participate in histamine inactivation in vivo. Naunyn Schmiedebergs Arch Pharmacol 357(1):49–53
Baganz NL, Horton RE, Calderon AS, Owens WA, Munn JL, Watts LT, Koldzic-Zivanovic N, Jeske NA, Koek W, Toney GM, Daws LC (2008) Organic cation transporter 3: keeping the brake on extracellular serotonin in serotonin-transporter-deficient mice. Proc Natl Acad Sci USA 105(48):18976–18981. doi:10.1073/pnas.0800466105
Pickel VM, Chan J (1999) Ultrastructural localization of the serotonin transporter in limbic and motor compartments of the nucleus accumbens. J Neurosci 19(17):7356–7366
Takeda H, Inazu M, Matsumiya T (2002) Astroglial dopamine transport is mediated by norepinephrine transporter. Naunyn Schmiedebergs Arch Pharmacol 366(6):620–623. doi:10.1007/s00210-002-0640-0
Giros B, el Mestikawy S, Bertrand L, Caron MG (1991) Cloning and functional characterization of a cocaine-sensitive dopamine transporter. FEBS Lett 295(1–3):149–154
Ramamoorthy S, Bauman AL, Moore KR, Han H, Yang-Feng T, Chang AS, Ganapathy V, Blakely RD (1993) Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci USA 90(6):2542–2546
Demchyshyn LL, Pristupa ZB, Sugamori KS, Barker EL, Blakely RD, Wolfgang WJ, Forte MA, Niznik HB (1994) Cloning, expression, and localization of a chloride-facilitated, cocaine-sensitive serotonin transporter from Drosophila melanogaster. Proc Natl Acad Sci USA 91(11):5158–5162
Gasser PJ, Lowry CA, Orchinik M (2006) Corticosterone-sensitive monoamine transport in the rat dorsomedial hypothalamus: potential role for organic cation transporter 3 in stress-induced modulation of monoaminergic neurotransmission. J Neurosci 26(34):8758–8766. doi:10.1523/JNEUROSCI.0570-06.2006
Baganz N, Horton R, Martin K, Holmes A, Daws LC (2010) Repeated swim impairs serotonin clearance via a corticosterone-sensitive mechanism: organic cation transporter 3, the smoking gun. J Neurosci 30(45):15185–15195. doi:10.1523/JNEUROSCI.2740-10.2010
Grundemann D, Liebich G, Kiefer N, Koster S, Schomig E (1999) Selective substrates for non-neuronal monoamine transporters. Mol Pharmacol 56(1):1–10
Schomig E, Lazar A, Grundemann D (2006) Extraneuronal monoamine transporter and organic cation transporters 1 and 2: a review of transport efficiency. Handb Exp Pharmacol 175:151–180
Amphoux A, Vialou V, Drescher E, Bruss M, Mannoury La Cour C, Rochat C, Millan MJ, Giros B, Bonisch H, Gautron S (2006) Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain. Neuropharmacology 50(8):941–952. doi:10.1016/j.neuropharm.2006.01.005
Duan H, Wang J (2010) Selective transport of monoamine neurotransmitters by human plasma membrane monoamine transporter and organic cation transporter 3. J Pharmacol Exp Ther 335(3):743–753. doi:10.1124/jpet.110.170142
Cui M, Aras R, Christian WV, Rappold PM, Hatwar M, Panza J, Jackson-Lewis V, Javitch JA, Ballatori N, Przedborski S, Tieu K (2009) The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway. Proc Natl Acad Sci USA 106(19):8043–8048. doi:10.1073/pnas.0900358106
Gasser PJ, Orchinik M, Raju I, Lowry CA (2009) Distribution of organic cation transporter 3, a corticosterone-sensitive monoamine transporter, in the rat brain. J Comp Neurol 512(4):529–555. doi:10.1002/cne.21921
Zhu P, Hata R, Ogasawara M, Cao F, Kameda K, Yamauchi K, Schinkel AH, Maeyama K, Sakanaka M (2012) Targeted disruption of organic cation transporter 3 (Oct3) ameliorates ischemic brain damage through modulating histamine and regulatory T cells. J Cereb Blood Flow Metab 32(10):1897–1908. doi:10.1038/jcbfm.2012.92
Vialou V, Balasse L, Callebert J, Launay JM, Giros B, Gautron S (2008) Altered aminergic neurotransmission in the brain of organic cation transporter 3-deficient mice. J Neurochem 106(3):1471–1482. doi:10.1111/j.1471-4159.2008.05506.x
Krzan M, Schwartz JP (2006) Histamine transport in neonatal and adult astrocytes. Inflamm Res 55(Suppl 1):S36–S37. doi:10.1007/s00011-005-0031-3
Schwartz JP, Wilson DJ (1992) Preparation and characterization of type 1 astrocytes cultured from adult rat cortex, cerebellum, and striatum. Glia 5(1):75–80. doi:10.1002/glia.440050111
Tuomi JM, Voorbraak F, Jones DL, Ruijter JM (2010) Bias in the Cq value observed with hydrolysis probe based quantitative PCR can be corrected with the estimated PCR efficiency value. Methods 50(4):313–322. doi:10.1016/j.ymeth.2010.02.003
Rose CR, Waxman SG, Ransom BR (1998) Effects of glucose deprivation, chemical hypoxia, and simulated ischemia on Na+ homeostasis in rat spinal cord astrocytes. J Neurosci 18(10):3554–3562
Chibalin AV, Heiny JA, Benziane B, Prokofiev AV, Vasiliev AV, Kravtsova VV, Krivoi II (2012) Chronic nicotine modifies skeletal muscle Na, K-ATPase activity through its interaction with the nicotinic acetylcholine receptor and phospholemman. PLoS ONE 7(3):e33719. doi:10.1371/journal.pone.0033719
Dahlin A, Xia L, Kong W, Hevner R, Wang J (2007) Expression and immunolocalization of the plasma membrane monoamine transporter in the brain. Neuroscience 146(3):1193–1211. doi:10.1016/j.neuroscience.2007.01.072
Daws LC (2009) Unfaithful neurotransmitter transporters: focus on serotonin uptake and implications for antidepressant efficacy. Pharmacol Ther 121(1):89–99. doi:10.1016/j.pharmthera.2008.10.004
Wu X, Kekuda R, Huang W, Fei YJ, Leibach FH, Chen J, Conway SJ, Ganapathy V (1998) Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain. J Biol Chem 273(49):32776–32786
Arndt P, Volk C, Gorboulev V, Budiman T, Popp C, Ulzheimer-Teuber I, Akhoundova A, Koppatz S, Bamberg E, Nagel G, Koepsell H (2001) Interaction of cations, anions, and weak base quinine with rat renal cation transporter rOCT2 compared with rOCT1. Am J Physiol Renal Physiol 281(3):F454–F468
Hayer-Zillgen M, Bruss M, Bonisch H (2002) Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3. Br J Pharmacol 136(6):829–836. doi:10.1038/sj.bjp.0704785
Perdan K, Kobe Z, Krzan M (2009) Nature of histamine transport in neonatal rat cultured type 1 astrocytes–organic cation transporters are not involved. Inflamm Res 58(Suppl 1):32–33. doi:10.1007/s00011-009-0655-9
Huszti Z (1998) Carrier-mediated high affinity uptake system for histamine in astroglial and cerebral endothelial cells. J Neurosci Res 51(5):551–558. doi:10.1002/(SICI)1097-4547(19980301)51:5<551:AID-JNR1>3.0.CO;2-E
Huszti Z (2003) Histamine uptake into non-neuronal brain cells. Inflamm Res 52(Suppl 1):S03–S06
Giannoni P, Passani MB, Nosi D, Chazot PL, Shenton FC, Medhurst AD, Munari L, Blandina P (2009) Heterogeneity of histaminergic neurons in the tuberomammillary nucleus of the rat. Eur J Neurosci 29(12):2363–2374. doi:10.1111/j.1460-9568.2009.06765.x
Rinne JO, Anichtchik OV, Eriksson KS, Kaslin J, Tuomisto L, Kalimo H, Roytta M, Panula P (2002) Increased brain histamine levels in Parkinson’s disease but not in multiple system atrophy. J Neurochem 81(5):954–960
Carfagna MA, Muhoberac BB (1993) Interaction of tricyclic drug analogs with synaptic plasma membranes: structure-mechanism relationships in inhibition of neuronal Na+/K(+)-ATPase activity. Mol Pharmacol 44(1):129–141
Sanganahalli BG, Joshi PG, Joshi NB (2000) Differential effects of tricyclic antidepressant drugs on membrane dynamics–a fluorescence spectroscopic study. Life Sci 68(1):81–90
Sweet DH, Miller DS, Pritchard JB (2001) Ventricular choline transport: a role for organic cation transporter 2 expressed in choroid plexus. J Biol Chem 276(45):41611–41619. doi:10.1074/jbc.M108472200
Koepsell H, Lips K, Volk C (2007) Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharm Res 24(7):1227–1251. doi:10.1007/s11095-007-9254-z
Engel K, Wang J (2005) Interaction of organic cations with a newly identified plasma membrane monoamine transporter. Mol Pharmacol 68(5):1397–1407. doi:10.1124/mol.105.016832
Engel K, Zhou M, Wang J (2004) Identification and characterization of a novel monoamine transporter in the human brain. J Biol Chem 279(48):50042–50049. doi:10.1074/jbc.M407913200
Vialou V, Balasse L, Dumas S, Giros B, Gautron S (2007) Neurochemical characterization of pathways expressing plasma membrane monoamine transporter in the rat brain. Neuroscience 144(2):616–622. doi:10.1016/j.neuroscience.2006.09.058
Inazu M, Takeda H, Maehara K, Miyashita K, Tomoda A, Matsumiya T (2006) Functional expression of the organic cation/carnitine transporter 2 in rat astrocytes. J Neurochem 97(2):424–434. doi:10.1111/j.1471-4159.2006.03757.x
Inazu M, Takeda H, Matsumiya T (2005) Molecular and functional characterization of an Na + -independent choline transporter in rat astrocytes. J Neurochem 94(5):1427–1437. doi:10.1111/j.1471-4159.2005.03299.x
Ohashi R, Tamai I, Nezu Ji J, Nikaido H, Hashimoto N, Oku A, Sai Y, Shimane M, Tsuji A (2001) Molecular and physiological evidence for multifunctionality of carnitine/organic cation transporter OCTN2. Mol Pharmacol 59(2):358–366
Codeluppi S, Gregory EN, Kjell J, Wigerblad G, Olson L, Svensson CI (2011) Influence of rat substrain and growth conditions on the characteristics of primary cultures of adult rat spinal cord astrocytes. J Neurosci Methods 197(1):118–127. doi:10.1016/j.jneumeth.2011.02.011
Kimelberg HK, Goderie SK, Conley PA, Higman S, Goldschmidt R, Amundson RH (1992) Uptake of [3H]serotonin and [3H]glutamate by primary astrocyte cultures. I. Effects of different sera and time in culture. Glia 6 (1):1–8. doi:10.1002/glia.440060102
Amundson RH, Goderie SK, Kimelberg HK (1992) Uptake of [3H]serotonin and [3H]glutamate by primary astrocyte cultures. II. Differences in cultures prepared from different brain regions. Glia 6(1):9–18. doi:10.1002/glia.440060103
Molina-Hernandez A, Diaz NF, Arias-Montano JA (2012) Histamine in brain development. J Neurochem 122(5):872–882. doi:10.1111/j.1471-4159.2012.07863.x
Nishibori M, Oishi R, Saeki K (1984) Histamine turnover in the brain of different mammalian species: implications for neuronal histamine half-life. J Neurochem 43(6):1544–1549
Oishi R, Nishibori M, Saeki K (1984) Regional differences in the turnover of neuronal histamine in the rat brain. Life Sci 34(7):691–699
Hough LB, Khandelwal JK, Green JP (1984) Histamine turnover in regions of rat brain. Brain Res 291(1):103–109
Acknowledgments
This work was supported by the research grant P3-067, J1-2014 of Ministry of Higher Education, Science and Technology, Republic of Slovenia. We greatly appreciate technical assistance of Mrs Jožica Košir.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Perdan-Pirkmajer, K., Pirkmajer, S., Raztresen, A. et al. Regional Characteristics of Histamine Uptake into Neonatal Rat Astrocytes. Neurochem Res 38, 1348–1359 (2013). https://doi.org/10.1007/s11064-013-1028-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-013-1028-x